ZYVERSA THERAPEUTICS, INC. Litigation Settlement, Amount Awarded to Other Party
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Litigation Settlement, Amount Awarded to Other Party of $117.53 thousand as of 2026-04-15, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:LitigationSettlementAmountAwardedToOtherParty · last filed 2026-05-13
- 2026-04-15: Litigation Settlement, Amount Awarded to Other Party $117.53K.
- 2024-12-31: Litigation Settlement, Amount Awarded to Other Party 5 month $268.97K.
- 2024-09-30: Litigation Settlement, Amount Awarded to Other Party $87.48K.
- 2024-08-31: Litigation Settlement, Amount Awarded to Other Party $81.83K.
| Period end | Litigation Settlement, Amount Awarded to Other Party | Litigation Settlement, Amount Awarded to Other Party as first filed | Litigation Settlement, Amount Awarded to Other Party 5 month |
|---|---|---|---|
| 2026-04-15 | $117.53K 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | $268.97K 10-K · filed 2025-03-27 | ||
| 2024-09-30 | $87.48K 10-Q · filed 2024-11-14 | ||
| 2024-08-31 | $81.83K 10-Q · filed 2024-11-14 | ||
| 2024-07-31 | $76.45K 10-Q · filed 2024-11-14 | ||
| 2024-07-01 | $144.30K 10-Q · filed 2026-05-13 | $162.80K 10-Q · filed 2024-08-09 | |
| 2024-06-30 | $923.88K 10-Q · filed 2026-05-13 | $992.18K 10-Q · filed 2024-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |